BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 18638431)

  • 1. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation.
    Nuki G
    Curr Rheumatol Rep; 2008 Jul; 10(3):218-27. PubMed ID: 18638431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine.
    Chia EW; Grainger R; Harper JL
    Br J Pharmacol; 2008 Mar; 153(6):1288-95. PubMed ID: 18264123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.
    Cronstein BN; Sunkureddi P
    J Clin Rheumatol; 2013 Jan; 19(1):19-29. PubMed ID: 23319019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages.
    Wang Y; Viollet B; Terkeltaub R; Liu-Bryan R
    Ann Rheum Dis; 2016 Jan; 75(1):286-94. PubMed ID: 25362043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of colchicine in the treatment of gout.
    Dalbeth N; Lauterio TJ; Wolfe HR
    Clin Ther; 2014 Oct; 36(10):1465-79. PubMed ID: 25151572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine--Update on mechanisms of action and therapeutic uses.
    Leung YY; Yao Hui LL; Kraus VB
    Semin Arthritis Rheum; 2015 Dec; 45(3):341-50. PubMed ID: 26228647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urate crystals, inflammation, and colchicine.
    McCarty DJ
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S20-4. PubMed ID: 18240262
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of acute and chronic gouty arthritis: present state-of-the-art.
    Schlesinger N
    Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Something old, something new--colchicine in the 21st century.
    Cronstein BN
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1141-2. PubMed ID: 19876781
    [No Abstract]   [Full Text] [Related]  

  • 10. Doliroside A attenuates monosodium urate crystals-induced inflammation by targeting NLRP3 inflammasome.
    Wei H; Hu C; Xie J; Yang C; Zhao Y; Guo Y; Mei Z; Chen L; Lan Z
    Eur J Pharmacol; 2014 Oct; 740():321-8. PubMed ID: 25064339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat.
    Huang J; Zhu M; Tao Y; Wang S; Chen J; Sun W; Li S
    J Pharm Pharmacol; 2012 Aug; 64(8):1119-27. PubMed ID: 22775215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-κB Activation.
    Dhanasekar C; Kalaiselvan S; Rasool M
    PLoS One; 2015; 10(12):e0145093. PubMed ID: 26709520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine: New Insights to an Old Drug.
    Stack J; Ryan J; McCarthy G
    Am J Ther; 2015; 22(5):e151-7. PubMed ID: 24100258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis.
    Torres R; Macdonald L; Croll SD; Reinhardt J; Dore A; Stevens S; Hylton DM; Rudge JS; Liu-Bryan R; Terkeltaub RA; Yancopoulos GD; Murphy AJ
    Ann Rheum Dis; 2009 Oct; 68(10):1602-8. PubMed ID: 19528034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of acute flares when initiating febuxostat for chronic gouty arthritis in a real-world clinical setting.
    Yu J; Qiu Q; Liang L; Yang X; Xu H
    Mod Rheumatol; 2018 Mar; 28(2):339-344. PubMed ID: 28485997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients with interval gout be treated with urate lowering drugs?
    Fam AG
    J Rheumatol; 1995 Sep; 22(9):1621-3. PubMed ID: 8523333
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra.
    Joosten LA; Crişan TO; Azam T; Cleophas MC; Koenders MI; van de Veerdonk FL; Netea MG; Kim S; Dinarello CA
    Ann Rheum Dis; 2016 Jun; 75(6):1219-27. PubMed ID: 26174021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Colchicine].
    Ben Slama L; Djemil M
    Rev Stomatol Chir Maxillofac; 2002 Apr; 103(2):128-9. PubMed ID: 11997742
    [No Abstract]   [Full Text] [Related]  

  • 19. Colchicine in Gout: An Update.
    Pascart T; Richette P
    Curr Pharm Des; 2018; 24(6):684-689. PubMed ID: 29336252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gouty arthritis: understanding the disease state and management options in primary care.
    Sunkureddi P
    Adv Ther; 2011 Sep; 28(9):748-60. PubMed ID: 21894471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.